PMD Device Solutions AB's Days Sales Outstanding for the
three
months ended in Sep. 2024 was 289.09.
PMD Device Solutions AB's Days Inventory for the
three
months ended in Sep. 2024 was 62.6.
PMD Device Solutions AB's Days Payable for the
three
months ended in Sep. 2024 was 1318.02.
Therefore, PMD Device Solutions AB's Cash Conversion Cycle (CCC) for the
three
months ended in Sep. 2024 was -966.33.
PMD Device Solutions AB (OSTO:PMDS) Cash Conversion Cycle Explanation
Generally, the lower this number is, the better for the company. Although it should be combined with other metrics (such as ROE % and ROA %), it can be especially useful for comparing close competitors, because the company with the lowest CCC is often the one with better management.
Be Aware
CCC is most effective with retail-type companies, which have inventories that are sold to customers. Consulting businesses, software companies and insurance companies are all examples of companies for whom this metric is meaningless.
The CCC is one of several tools that can help you evaluate management, especially if it is calculated for several consecutive time periods and for several competitors. Decreasing or steady CCCs are good, while rising ones should motivate you to dig a bit deeper.
PMD Device Solutions AB Cash Conversion Cycle Related Terms
PMD Device Solutions AB Cash Conversion Cycle Historical Data
* Premium members only.
The historical data trend for PMD Device Solutions AB's Cash Conversion Cycle can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PMD Device Solutions AB Cash Conversion Cycle Chart
OSTO:PMDS vs ABT, SYK, BSX: Cash Conversion Cycle Comparison
For the Medical Devices subindustry, PMD Device Solutions AB's Cash Conversion Cycle, along with its competitors' market caps and Cash Conversion Cycle data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PMD Device Solutions AB Cash Conversion Cycle vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, PMD Device Solutions AB's Cash Conversion Cycle distribution charts can be found below:
* The bar in red indicates where PMD Device Solutions AB's Cash Conversion Cycle falls into.
PMD Device Solutions AB Cash Conversion Cycle Calculation
Cash Conversion Cycle (CCC) measures how fast a company can convert cash on hand into even more cash on hand. This metric looks at the amount of time needed to sell inventory, the amount of time needed to collect receivables and the length of time the company is afforded to pay its bills without incurring penalties.
Cash Conversion Cycle is one of several measures of management effectiveness.
PMD Device Solutions AB's Cash Conversion Cycle for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Cash Conversion Cycle of -966.33 mean?
PMD Device Solutions AB (OSTO:PMDS) has a Cash Conversion Cycle of -966.33 as of Sep. 2024. Cash conversion cycle equals sum of days inventory and days sales outstanding less days payable. View historical data on PMD Device Solutions AB and its competitors.
Is PMD Device Solutions AB's Cash Conversion Cycle too high?
PMD Device Solutions AB's current Cash Conversion Cycle is -966.33. Overall, PMD Device Solutions AB has a GF Score™ of 4/100, reflecting its overall financial health beyond just this single metric.
How does PMD Device Solutions AB's Cash Conversion Cycle compare to ABT and SYK?
PMD Device Solutions AB's Cash Conversion Cycle of -966.33 can be compared against companies in the Medical Devices & Instruments industry. The industry median Cash Conversion Cycle is 156.96. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Conversion Cycle for a Medical Devices & Instruments company?
The median Cash Conversion Cycle among Medical Devices & Instruments companies is 156.96, based on 815 companies in the industry. Companies in the top quartile (top 25%) have a Cash Conversion Cycle significantly above this median, while those in the bottom quartile fall well below. However, Cash Conversion Cycle should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Conversion Cycle mean?
A high Cash Conversion Cycle can signal that a stock is expensive relative to its fundamentals. Cash conversion cycle equals sum of days inventory and days sales outstanding less days payable. View historical data on PMD Device Solutions AB and its competitors. For the Medical Devices & Instruments industry, the median Cash Conversion Cycle is 156.96 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PMD Device Solutions AB's current Cash Conversion Cycle is -966.33. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PMD Device Solutions AB stock overvalued right now?
PMD Device Solutions AB (OSTO:PMDS) has a current Cash Conversion Cycle of -966.33. The current Cash Conversion Cycle is -966.33. PMD Device Solutions AB's overall GF Score™ is 4/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Conversion Cycle calculated?
Cash Conversion Cycle is calculated from a company's financial statements. For PMD Device Solutions AB (OSTO:PMDS), the current Cash Conversion Cycle is -966.33 as of Sep. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
PMD Device Solutions AB develops and sells medical products for respiratory monitoring in both the hospital and homecare setting. Its primary product is RespiraSense, a solution used for monitoring respiratory rate to detect deterioration of a patient's general condition early and to avoid preventable respiratory failure and adverse patient outcomes. RespiraSense is, to the Company's knowledge, the world's only continuous, motion-tolerant respiratory rate monitor delivering class-leading reliability in measuring respiratory rate. RespiraSense is a novel technology that is commercialised in Europe, the UK, and FDA-cleared in the US.
4GF Score
Get the complete analysis for OSTO:PMDS
Cash Conversion Cycle is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSTO:PMDS has been successfully added to your 
